Clinical Trial Update: Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Apligraf to standard therapy for diabetic foot ulcers was terminated, according to the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• Apligraf

Snippet

Sponsor: Organogenesis | Conditions: Diabetic Foot | Phase 3 | Status: TERMINATED